New research focusing on heart attacks, specifically ST‐segment–elevation myocardial infarctions (STEMIs), has uncovered that socioeconomic, racial, and gendered disparities are associated with greater risk and that those ...
May 2, 2024
0
0
New data demonstrated that a left main (LM) bifurcation-specific novel scoring system (LM V-RESOLVE), based on three simple baseline angiographic findings, could help to rapidly discriminate lesions at risk of side branch ...
May 2, 2024
0
2
From 2000 to 2022, there was an increase in the lifetime risk for atrial fibrillation, according to a study published online April 17 in The BMJ.
Apr 22, 2024
0
0
A new guideline from the American College of Physicians (ACP) offers clinical recommendations for the use of newer pharmacological treatments of adults with type 2 diabetes. This is an update of ACP's 2017 guideline and is ...
Apr 19, 2024
0
4
Heart failure (HF) after myocardial infarction (MI) is a global health issue with a high mortality rate. Multiple molecular mechanisms are involved in the development of HF after MI. However, interventions targeting these ...
Apr 18, 2024
0
10
Myocardial infarction, more commonly known as a heart attack, is a leading cause of death worldwide. Biomarkers called plasma metabolites may play a key role in the physiological pathways involved in myocardial infarctions. ...
Apr 17, 2024
0
4
Referring people to a specialized rehabilitation program following a cardiac incident could reduce the chance they will be readmitted to hospital and potentially lower their risk of death, according to new Flinders University ...
Apr 11, 2024
0
0
A new meta-analysis shows sodium glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of major adverse cardiovascular events in patients with either diabetes at high risk of atherosclerotic cardiovascular disease (ASCVD), ...
Apr 8, 2024
0
0
About 800,000 people in the U.S. suffer a heart attack every year, and about 30% of them will go on to develop heart failure. There are limited treatments to prevent or slow that development.
Apr 8, 2024
0
0
For patients with acute myocardial infarction at risk for heart failure, empagliflozin reduces the risk for heart failure hospitalization, according to a study published online April 6 in Circulation to coincide with the ...
Apr 8, 2024
0
0
